Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 30,000 shares at $33.29 ($1.0M) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Scheduled sale ($1.0M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.29 | 8,527 | $284K | 27.5% |
| 2 | $34.28 | 9,991 | $343K | 33.1% |
| 3 | $35.32 | 9,821 | $347K | 33.6% |
| 4 | $36.16 | 1,661 | $60K | 5.8% |
| Total | $34.44 avg | 30,000 | $1.0M | 100% |
| Filing → |
| TXG | SELL | 2026-08-26 | $1.2M | — | Filing → |
| TXG | SELL | 2026-05-27 | $709K | — | Filing → |
| TXG | SELL | 2026-04-16 | $123K | — | Filing → |